7-Minute Assessment Revolutionizes CNS Trial Outcomes: CDR Attention Battery

By Helen Brooker, Senior Product Manager, and Pascal Goetghebeur, Clinical Principal for Cognition, Science & Medicine

Navigating the intricacies of clinical trials, particularly those focused on central nervous system (CNS) conditions, often presents hurdles in effectively screening and recruiting participants. This is a critical area, as CNS trials unfortunately face higher rates of poor trial results. Cognitive Drug Research (CDR) System Attention Battery's are a groundbreaking tool poised to revolutionize participant selection and monitoring, addressing some of the key challenges with CNS trials. The CDR System's remarkable accuracy and sensitivity, coupled with a user-friendly web-based interface, set it apart. Explore how this concise, seven-minute assessment is reshaping how clinical trial sponsors identify and track individuals participating in their studies.